Ardea Biosciences focuses on the development of small-molecule therapeutics for the treatment of serious diseases. Ardea’s most advanced clinical-stage product candidates include treatments for gout and cancer. Ardea also has acquired intellectual property and other assets pertaining to several classes of small-molecule therapeutics for the treatment of HIV and cancer. For more information visit the company’s Web site at www.ardeabiosciences.com
ROTH Capital Partners is a relationship-driven investment bank that primarily focuses on connecting small-cap publicly traded companies with institutional investors. This year’s annual ROTH conference will take place at The Ritz Carlton located in Dana Point, CA, on March 11-14. Bringing together executives from more than 400 growth companies, the 24th Annual ROTH Conference is one of the largest of its kind in the U.S. For more information on ROTH Capital Partners, visit www.roth.com
Let us hear your thoughts below: